Dexras1 blocks receptor-mediated heterologous sensitization of adenylyl cyclase 1
- PMID: 15913563
- DOI: 10.1016/j.bbrc.2005.05.041
Dexras1 blocks receptor-mediated heterologous sensitization of adenylyl cyclase 1
Abstract
Dexras1/AGS1/RasD1 is a member of the Ras superfamily of monomeric G proteins and has been suggested to disrupt receptor-G protein signaling. We examined the ability of Dexras1 to modulate dopamine D(2L) receptor regulation of adenylyl cyclase (AC) type 1 in HEK293 cells. Acute D(2L) receptor-mediated inhibition of A23187-stimulated AC1 activity (IC50, 4.0+/-1.4 nM; 50+/-3% inhibition) was not altered in the presence of Dexras1 (IC50, 2.4+/-1.3 nM, 50+/-1% inhibition); however, Dexras1 blocked acute D(2L) receptor-mediated activation of ERK 1/2 by approximately 50%. Heterologous sensitization of AC1 induced by persistent activation of D(2L) receptors was completely blocked by Dexras1 under basal and A23187-stimulated conditions. The block of sensitization was concentration-dependent and was not observed with a nucleotide binding-deficient Dexras1G31V mutant. Sensitization of AC1 was Gbetagamma-dependent as demonstrated using the C-terminus of beta-adrenergic receptor kinase (betaARK-ct). These data suggest that Dexras1 selectively regulates receptor-mediated Gbetagamma signaling pathways.
Similar articles
-
Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.J Pharmacol Exp Ther. 2001 Jun;297(3):1201-9. J Pharmacol Exp Ther. 2001. PMID: 11356947
-
D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.Neuropharmacology. 2006 Apr;50(5):576-84. doi: 10.1016/j.neuropharm.2005.11.004. Epub 2005 Dec 27. Neuropharmacology. 2006. PMID: 16376953
-
Dexras1 inhibits adenylyl cyclase.Biochem Biophys Res Commun. 2004 Apr 2;316(2):307-12. doi: 10.1016/j.bbrc.2004.02.049. Biochem Biophys Res Commun. 2004. PMID: 15020218
-
Sensitization of adenylate cyclase by Galpha i/o-coupled receptors.Pharmacol Ther. 2005 Jun;106(3):405-21. doi: 10.1016/j.pharmthera.2004.12.005. Epub 2005 Mar 2. Pharmacol Ther. 2005. PMID: 15922020 Review.
-
Resetting the clock: Dexras1 defines a path.Neuron. 2004 Sep 2;43(5):603-4. doi: 10.1016/j.neuron.2004.08.029. Neuron. 2004. PMID: 15339641 Review.
Cited by
-
nNOS-CAPON blockers produce anxiolytic effects by promoting synaptogenesis in chronic stress-induced animal models of anxiety.Br J Pharmacol. 2020 Aug;177(16):3674-3690. doi: 10.1111/bph.15084. Epub 2020 May 28. Br J Pharmacol. 2020. PMID: 32343840 Free PMC article.
-
Role of estrogen and RAS signaling in repeated implantation failure.BMB Rep. 2018 May;51(5):225-229. doi: 10.5483/bmbrep.2018.51.5.045. BMB Rep. 2018. PMID: 29519295 Free PMC article. Review.
-
Activators of G protein signaling exhibit broad functionality and define a distinct core signaling triad.Mol Pharmacol. 2014 Mar;85(3):388-96. doi: 10.1124/mol.113.090068. Epub 2013 Dec 3. Mol Pharmacol. 2014. PMID: 24302560 Free PMC article. Review.
-
Expression of Rasd1 in mouse endocrine pituitary cells and its response to dexamethasone.Stress. 2021 Sep;24(5):659-666. doi: 10.1080/10253890.2021.1907340. Epub 2021 Apr 10. Stress. 2021. PMID: 33840368 Free PMC article.
-
The molecular gatekeeper Dexras1 sculpts the photic responsiveness of the mammalian circadian clock.J Neurosci. 2006 Dec 13;26(50):12984-95. doi: 10.1523/JNEUROSCI.4253-06.2006. J Neurosci. 2006. PMID: 17167088 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous